VectorY Raises €129M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Forbion Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Forbion Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Forbion Ventures Today - Breaking & Trending Today
enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company
/PRNewswire/ - enGene Holdings Inc. ("enGene" or the "Company,") (NASDAQ: ENGN) today announced the completion of the previously announced business combination...
Source: prnewswire.com
EnGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies - Form 8-K
EnGene, Inc. and Forbion European Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company... | May 17, 2023
Source: marketscreener.com
NorthSea Therapeutics B.V.: NorthSea Therapeutics Provides Clinical Update Reflecting Progress Across NASH And Metabolic Disorders Programmes
NorthSea Therapeutics now has three phase II clinical stage assets in development based on its SEFA platform Top line results of Phase 2b ICONA trial with lead programme icosabutate for NASH expected
Source: finanznachrichten.de
NorthSea Therapeutics Appoints Morris J. Birnbaum to the Board
Former Pfizer Internal Medicine CSO joins the Board as an independent board member NorthSea Therapeutics B.V. ('NST'), a biotech company developing novel and innovative strategies for the treatment
Source: finanznachrichten.de